Health
Second study testing a COVID-19 antibody drug reports setback – 8News
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavorable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News23 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General23 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General23 hours agoWhy do states and territories have different school holidays?